COVID-NOW NHS Oncology Workforce study: 2nd Survey NOW OPEN

Are you a UK NHS employee working within an oncology hospital department?

Would you like to contribute to some important research exploring the impact of COVID-19 on the oncology workforce?

 

What is the research about?

The purpose of the research is to:

Understand the experiences of NHS oncology staff
Understand what factors might influence wellbeing, burnout and coping
Understand what changes and support should be offered to help support the oncology workforce during COVID-19 and beyond

What does taking part involve?

Complete a short, anonymous survey by 23rd April. It should take around 15 minutes to complete and can very done on a phone, tablet or computer.

 

To access the survey all you need to do it follow the link here:
COVID-NOW T2 SURVEY

 

We plan to have a further survey this year to track experiences and the longer term impact of COVID-19 in the NHS oncology workforce.

Who is carrying out the Research?

The study sponsor is The Royal Marsden NHS Foundation Trust (Chief Investigator Dr Susana Banerjee). The academic collaboration includes researchers at Lancaster University.

The study (HRA approved) is funded by the Royal Marsden Cancer Charity (donation from Lady Garden Foundation) and is supported by The Association of Cancer Physicians (ACP), Faculty of Clinical Oncology of the Royal College of Radiologists (RCR) and British Oncology Pharmacy Association (BOPA).

If you require further information please email: [email protected]

 

Please do share this link with colleagues, associates and friends who you think may be interested in taking part.

Thank you for your time!

The BOPA Committee

Latest News

By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article
By BOPA on 27th October 2025

Celebrating Success in the BOPA Immunotherapy Group

The BOPA Immunotherapy Cancer Advisory Group, have recently done some research into immune-related cardiac toxicity; both the monitoring for, and management of, these rare but serious adverse effects. Simon Jenkinson,…

Read article
By BOPA on 27th October 2025

Celebrating Black History Month – Celebrating Excellence with Gisela Abbam

In celebration of Black History Month, the Kingston University BAME staff network  is excited to invite you to an inspiring session with Gisela Abbam,  Chair of the General Pharmaceutical Council (GPhC). Gisela…

Read article